238 results about "Chronic colitis" patented technology

The invention relates to a traditional Chinese pharmaceutical composition for treating chronic colitis and process for preparation, wherein the composition mainly comprises campanumaea pilosula 3j00g, atractylodes rhizome 100g, white atractylodes rhizome 150g, slice of aconite 100g, flavescent sophora root 60g, Chinese pulsatilla root 60g, psoralea fruit 60g, haw 100g, pomegranate bark 60g, smoked plum 100g, chebula fruit 100g, coptis root 60g, herba patriniae 200g, orange peel 100g, mace nutmeg 100g, banksia rose 50g, ledebouriella root 50g, dried ginger 100g, hairy vein agrimony 200g, hyacinth bean 100g, Chinese yam 150g, poria cocos wolf 100g, root of herbaceous peony 150g, and licorice root 50g.

The invention relates to compound probiotics and a preparation method thereof. The compound probiotics comprise ten or more probiotics and two or more prebiotics. The invention also provides the preparation method of the compound probiotics. The preparation method comprises the following steps: firstly, mixing the compound probiotics according to the proportion, passing through a sieve with 80 to 120 meshes, then taking siftage and weighing; secondly, mixing the weighed materials; thirdly, tabletting mixed materials. According to the compound probiotics and the preparation method thereof disclosed by the invention, by scientifically mixing the probiotics with the prebiotics, the efficacy of the compound probiotics is effectively improved, living cell concentration is high, and the efficacy realizing time of the probiotics is shortened; compared with other products in the market, the compound probiotics have the advantages that acid and bile salt resisting capabilities are good; if the compound probiotics are administrated for one month, the improvement rate of constipation reaches 100 percent, the improvement rate of chronic colitis reaches 100 percent, the positive-to-negative rate of helicobacter pylori reaches 82 percent, the rehabilitation rate of chemical liver injury reaches 88 percent, the rehabilitation rate of anaphylactic rhinitis is 91 percent, the rehabilitation rate of female vaginitis reaches 93 percent, the improvement rate of phlegm-dampness constitution reaches 100 percent, the improvement rate of damp-heat constitution reaches 100 percent, and the improvement rate of acnes reaches 98 percent.

The invention provides a Chinese medicinal preparation for treating chronic colitis, which comprises the following components: 10 to 15g of astragalus, 7 to 10g of white paeony root, 10 to 15g of divaricate saposhnikovia root, 10 to 15g of peach seed, 7 to 10g of safflower, 7 to 10g of gordon euryale seed, 10 to 20g of cinnamomvine, 15 to 30g of Chinese angelica, 10 to 20g of Indian buead, 10 to 15g of szechuan lovage rhizome, 10 to 15g of radix bupleuri, 10 to 20g of large-headed atractylodes, 7 to 10g of liquoric root, 10 to 15g of dried orange peel and 10 to 12g of szechwon tangshen root. The Chinese medicinal preparation has the effects of strengthening the spleen and replenishing qi, promoting blood circulation by removing blood stasis and stopping diarrhea, and can treat the chronic colitis caused by spleen insufficiency and dampness.

The present invention relates to a Chinese medicine for effectively curing chronic colitis and ulcerative colitis with obvious therapeutic effect. Said Chinese medicine is made up by using 10 Chinese medicinal materials of valeriana jatamansi, scutellaria root, lonicera flower, notoginseng, astragalus root and others through a certain preparation process.

An application of proanthocyanidin in preparing the medicines for treating ulcerative colitis and non-bacteria chronic colitis is disclosed.

The present invention relates to immunoglobulin single variable domain sequences that are directed against (as de-fined herein) OX40L, as well as to compounds or constructs, and in particular proteins and polypeptides, that comprise or essentially consist of one or more such immunoglobulin single variable domain sequences. In particular these immunoglobulin single variable domain sequences can block binding of OX40L to OX40. The immunoglobulin single variable domains, compounds and constructs can be used for prophylactic, therapeutic or diagnostic purposes, such as for the treatment of inflammatory disease and / or disorder such as e.g. asthma, allergic asthma, chronic colitis, Crohn's disease, inflammatory bowel disease, and / or arthrosclerosis.

The invention belongs to the field of traditional Chinese medicines, in particular to a traditional Chinese medicine for treating chronic colitis, which comprises the following raw materials in certain parts by weight of astragalus root, prepared liquorice, rhizoma atractylodis, fructus forsythiae, white atractylodes rhizome, cherokee rose fruit, herba lycopi, orange peel, phoenix-tail fern, swamp mahogany leaf, guava leaf, Japanese polygala, cacumen biotae, herba agrimoniae and dwarf mountain pine. The invention has simple preparation, good absorption effect, remarkable treatment effect, no side effects and high safety, and is beneficial to lightening the symptoms of patients.

The invention involves methods and materials for treating and preventing non-invasive fungus-induced mucositis. Specifically, the invention involves administrating an antifungal agent such that it contact mucus in an amount, at a frequency, and for a duration effective to prevent, reduce, or eliminate non-invasive fungus-induced rhinosinusitis. This invention also provides methods and materials for diagnosing non-invasive fungus-induced rhinosinusitis and culturing non-invasive fungus from a mammalian mucus sample as well as specific antifungal formulations and medical devices for treating and preventing non-invasive fungus-induced rhinosinusitis. In addition, the invention provides methods and materials for treating and preventing other non-invasive fungus-induced mucositis conditions such as chronic otitis media, chronic colitis, and Crohn's disease. Further, the invention involves methods and materials for treating and preventing chronic asthma symptoms.

The invention relates to a capsule for treating enteritis which contains following raw material of active constituents (by weight ratio): coptis root 10-15 parts, banksia rose 15-20 parts, white peony root 25-30 parts, dried orange peel 25-30 parts, white atractylodes rhizome 20-25 parts, ledebouriella root 20-25 parts, astragalus root 25-30 part, evodia rutaecarpa benth 10-15 parts, schisandra fruit 20-25 part, mace nutmeg 20-30 parts, dried ginger 5-15 parts, psoralea fruit 10-15 parts, notoginseng 5-15 parts.

The Chinese herbal medicine for treating piles is prepared with honeysuckle, dandelion, agrimonia herb, pearl powder, skullcap root and other 12 kinds of Chinese medicinal materials. It has the functions of promoting venous blood circulation, decomposing muscle fibril, eliminating abscess around anus, preventing varicosity, etc. It has high curative effect on various piles in different stages, hematochezia and anal fissure as well as chronic colonitis, and no any irritability and toxic side effect. In addition, the medicine is prepared into capsule easy to carry about and is low in cost.

The invention discloses Chinese medicinal enema decoction for treating colonitis, which solves the problems of large side effect, high relapse rate, unsatisfactory long-term effect, lasting state of illness, easy relapse after healing and troublesome treatment of the traditional method for treating the colonitis by using Western medicine. The Chinese medicinal enema decoction for treating the colonitis comprises the following medicines serving as raw materials in part by weight: 10 to 35 parts of bletilla, 10 to 35 parts of Chinese pulsatilla root, 10 to 35 parts of sargentgloryvine stem, 10 to 35 parts of amur corktree bark, 15 to 35 parts of lightyellow sophora root, 12 to 35 parts of feverfew, 5 to 25 parts of Chinese gall, 10 to 25 parts of garden burnet root, 5 to 20 parts of dragon's blood, 6 to 15 parts of powdered notoginseng root, 3 to 10 parts of golden thread and 3 to 6 parts of alum. Due to the adoption of the traditional Chinese medicines, the Chinese medicinal enema decoction has the advantages of treatment of both symptoms and root causes, treatment aiming at the root of disease, treatment according to syndrome differentiation and increment / decrement according to syndrome, and the characteristics of simple and understandable treatment method, low price, no toxic or side effect, safety, reliability, wide applicable range, no pain to patients and easy acceptance.

The invention discloses a medicine composition for treating chronic ulcerative colitis. The medicine composition comprises, by weight, 90-150 parts of humifuse euphorbia herb, 10-60 parts of lucid ganoderma, 60-120 parts of garden burnet, 50-150 parts of folium callicarpae pedunculatae, 20-100 parts of radix sophorae flavescentis, 20-80 parts of hairyvein agrimony, 50-110 parts of madder, 10-70 parts of Poria cocos, 10-70 parts of Semen Euryales, 10-80 parts of Cacumen biotae, 10-80 parts of pagoda tree flowers, 10-70 parts of cuttlebone, 5-40 parts of gallnut, 10-70 parts of rhizoma bletillae, 0-40 parts of Acacia catechu and 0-40 parts of pseudo-ginseng. A preparation process of the medicine composition comprises the steps of weighing out all pharmacodynamic raw materials according to a formula and uniformly mixing all pharmacodynamic raw materials through crushing, water extraction concentration, alcohol extraction concentration or a method combining the crushing, the water extraction concentration and the alcohol extraction concentration, so that the medicine composition can be obtained. The medicine composition is prepared with Chinese herbal medicines serving as raw materials, can relieve internal heat, promote tissue regeneration and support healthy energy, is particularly applicable to treatment of ulcerative colitis, Crohn's diseases, chronic colitis, radioactive colitis and proctitis, irritable bowel syndrome and the like and can solve the problems that antibiotics are taken for a long term, beneficial bacterium drugs are not ideal in effect and toxic and side effects are large.

The invention discloses spleen-tonifying stomach-nourishing health-care noodles, which comprise the following raw materials in part by weight: 3 to 8 parts of rice meal, 5 to 12 parts of corn meal, 60 to 85 parts of wheat meal, 5 to 10 parts of millet, 2 to 5 parts of white radish meal, 1 to 4 parts of hawthorn fruit, 1 to 3 parts of Szechwan tangshen root, 1 to 5 parts of medlar, 1 to 2.5 parts of Indian buead, 1 to 3 parts of largehead atractylodes rhizome and 2 to 6 parts of medicated leaven. The health-care noodles are a new variety of noodles, allow the conventional noodles to have nutrition and health-care functions, do not have any side effect, have the effects of tonifying middle and replenishing qi, tonifying spleen and harmonizing stomach, and have obvious effects on gastrointestinal diseases such as chronic colitis, chronic gastrosis, long-term diarrhea, emaciation, inappetence, peptic ulcer and the like, so people ease worries of visiting doctors and taking medicines.

The invention discloses a traditional Chinese medicine preparation for treating chronic colitis and a preparation method thereof. The traditional Chinese medicine preparation are prepared from the following medicinal raw materials in parts by weight: 10-20 parts of pasqueflower, 10-20 parts of yam, 10-20 parts of bletilla, 10-20 parts of baikal skullcap root, 10-20 parts of radix sophorae flavescentis, 10-20 parts of nutmeg, 10-20 parts of bighead atractylodes rhizome, 10-20 parts of tuckahoe, 10-20 parts of garden burnet, 10-20 parts of bulbus allii macrostemi, 10-20 parts of pericarpium arecae, 10-20 parts of coptis, 10-20 parts of dried old orange peel, 10-20 parts of alum, 10-20 parts of bark of Chinese ash, 10-20 parts of focal divina commedia, 10-20 parts of fructus schizandrae, 10-20 parts of ginger and 10-20 parts of granatum. The traditional Chinese medicine preparation discloses by the invention has the functions of antidiarrheal and diminishing inflammation, resolving tetany and relieving pain, improving local blood circulation and metabolism, reinforcing the intestinal immune function and prompting the ulcer recovery. The traditional Chinese medicine preparation discloses by the invention is simple and convenient in preparation process, has small toxic and side effects, is conveniently applied, and is low in cost and easy to prepare. Furthermore, the traditional Chinese medicine preparation directly reaches the focus, so that the healing time is short, and the disease does not recur after being healed.

The invention discloses a traditional Chinese medicine composition for treating chronic colitis and its preparation method, the traditional Chinese medicine composition comprises the following bulk drugs by weight: 15-30 parts of cassia twig, 15-30 parts of Radix Paeoniae Alba, 15-30 parts of Sanguisorba officinalis, 15-30 parts of Radix Aconiti Lateralis Preparata, 12-25 parts of Evodia rutaecarpa, 10-20 parts of Pulsatilla chinensis, 10-20 parts of nutmeg, 10-20 parts of ash bark, 6-12 parts of jujube, 5-10 parts of galangal oleoresin, 4-8 parts of charred haw, 2-6 parts of Radix Glycyrrhizae Preparate and 2-6 parts of rhizoma coptidis. The clinical observation test of the curative effect proves that the traditional Chinese medicine composition has the efficacy of enlivening spleen and widening intestine, regulating vital energy and relieving asthma, promoting digestion and purgation, removing food retention and flatulence as well as alleviating pain, repressing upward perversion of Qi and warming middle energizer and the like, and the traditional Chinese medicine composition has the advantages of fast effectiveness, definite therapeutic effect, no toxic and side effect for clinical medication and good security.

The invention relates to a traditional Chinese medicine for curing intestine diarrhea. At present, there is no effective and ideal medicine for curing common diseases of chronic diarrhea, ulcerative colitis and irritable bowel syndrome diarrhea in the medical field. The traditional Chinese medicine for curing intestine diarrhea provided by the invention comprises the following components by weight part: 15 parts of rough atractylis ovata, 15 parts of rhizoma atractylodis macrocephalae, 20 parts of yam, 20 parts of Tuckahoe, 3 parts of pencil stone, 3 parts of fried semen plantaginis, 3 parts of rough semen plantaginis, 8 parts of alisma orientale, 20 parts of halloysitum rubrum, 10 parts of limonitum, 10 parts of terra frava usta, 5 parts of nutgall, 5 parts of calcined alum, 10 parts of hyacinth bean, 8 parts of alpinia katsumadai, 3 parts of fructus psoraleae, 10 parts of hawthorn coke, 5 parts of elecampane and 5 parts of notoginseng. The invention is used for curing chronic diarrhea, ulcerative colitis and irritable bowel syndrome diarrhea.

The invention relates to a colloid tartro-bismuthate and a drug preparation, a preparation method and application of the colloid tartro-bismuthate. The colloid tartro-bismuthate consists of tartaric acid, trivalent metal bismuth ion oxide or salt and low methoxyl-D-polygalacturonase; and the colloid tartro-bismuthate is subjected to centrifugal spraying and drying by dissolution, mixing, precipitation and other methods to form microcrystalline fine powdery colloid tartro-bismuthate. The drug has obvious treatment effect on chronic nonspecific ulcerative colitis, irritable bowel syndrome and chronic colonic inflammation, has good treatment effect on chronic atrophic gastritis and other stomach diseases, has small toxicity and side effect and belongs to a safe, nontoxic and effective drug of a gastroenterology department.

The invention relates to an edible composition formula with a mucous-membrane restoring function and a preparation process of a preparation thereof. The edible composition formula is characterized by comprising the following materials in parts by weight: 0.2 to 2 parts of sodium gualenate, 8 to 40 parts of chitosan and 2 to 58 parts of rosa roxburghii fruit powder / rosa roxburghii extract. The composition can be prepared into any pharmaceutically-acceptable preparation according to a conventional process by adding conventional auxiliary materials. The composition applied for protection has the effects of resisting inflammation and promoting healing of ulcers and can be widely used for preventing and treating oral ulcers, gastric ulcers and chronic colitis.

The invention discloses a Chinese herbal medicine for treating chronic colitis, which is prepared from the following components in parts by weight: 15-25 parts of coptis, 20-30 parts of Baikal skullcap root, 15-25 parts of kudzu root, 10-20 parts of Cortex Fraxini, 20-30 parts of wild spikenard root, 30-60 parts of cereus, 5-10 parts of lucid ganoderma, 20-30 parts of rhizoma atractylodis macrocephalae and 20-30 parts of Chinese yam. The Chinese herbal medicine is prepared by the following steps: adding water to the Chinese medicinal herbs and decocting three times, filtering, recycling the supernatants, evenly mixing, bottling, and sterilizing for later use. The coptis is used as the monarch material; the Baikal skullcap root and kudzu root are used as the minister materials; the red Cortex Fraxini, wild spikenard root and cereus are used as the assistant materials; and the lucid ganoderma, rhizoma atractylodis macrocephalae and Chinese yam are used as the guide materials. The Chinese herbal medicine has the advantages of simple equipment, low production cost, abundant medicine resources and no toxic or side effect, is simple to prepare, and is convenient and safe for patients to take. The oral aqueous liquor is simple to prepare and operate, has the advantages of low production cost, abundant medicine resources and no side effect, and is convenient and safe for patients to take.

The invention relates to a traditional Chinese medicine composition for treating chronic colitis and protitis, which comprises the following components in parts by weight: 6-40 parts of dried ginger, 6-30 parts of ossa draconis, 10-40 parts of umbellate pore fungus, 10-40 parts of fructus chebulae, 8-42 parts of myristica fragrans, 6-30 parts of prepared liquorice, 10-48 parts of red halloysite, 6-40 parts of dogwood, 6-38 parts of szechwan Chinaberry fruit, 6-45 parts of rhizoma alismatis, 3-15 parts of monkshood, 10-40 parts of yam, 6-40 parts of costustoot, 3-15 parts of goldthread, 8-25 parts of dangshen, 3-30 parts of hairyvein agrimony, 3-30 parts of tenodera aridifolia stoll and 3-30 parts of dried alum. Proved by clinical application for many years, the traditional Chinese medicine composition has the functions of tonifying the spleen and the kidney and regulating the intestines and stomach, achieves the purpose of treating both principal and secondary aspect of diseases, can not generate any toxic or side effect during the taking, overcomes the defects of many medicaments for treating the chronic colitis and protitis, solves the problem that the traditional western medicines cure the symptoms, but does not cure the cause.

The invention discloses a traditional Chinese medicinal enema for treating chronic colitis. According to the traditional Chinese medicinal science, the pathogenesis of chronic colitis is mainly due to syndromes of dampness-heat due to spleen deficiency and qi depression to blood stasis, especially develops in colonic mucosa and submucosa inflammation and ulcer changes, and is characterized by stomachache, diarrhea, mucous bloody stool and tenesmus in clinic. Therefore, traditional Chinese medicines, which have effects of clearing heat, drying damp, diminishing swelling, promoting granulation,removing pattogenic heat from the blood and toxic material from the body, relieving diarrhea, diminishing inflammation, resolving tetany and relieving pain, including traditional Chinese medicinal Swamp Mahogany Leaf, champion dutchmanspipe root, mongolian oak bark, Scutellaria baicalensis, cortex fraxini, Cape jasmine, Rhizoma Atractylodis Macrocephalae, licorice root, Codonopsis pilosula, cortex albiziae, fruits of Litsea rubescens, cortex cinnamomi and hurricane lamp, are selected to be made into the enema. Through clinical tests of our public health centre, the total effective rate of theenema reaches 96.3% and it is obviously better than a control group. In addition, patients have no adverse reaction after taking the medicine. Therefore, the medicine is worth of clinical popularization and application.

The present invention is method of treating chronic colitis. Decoction is prepared with 11 kinds of Chinese medicinal materials, including Dangshen, white atractylodes rhizome, baked ginger, prepared licorice, tuckahoe, etc in certain weight proportion, and through soaking in water for 0.5 hr, twice decocting and eliminating dregs. The decoction is taken once in the morning and once in the evening.

The invention discloses an oral administration pharmaceutical composition for treating chronic enteritis, wherein the active constituents include the following raw material herbs (by weight portion): and haw 12, atractylodes rhizome 6, Chinese yam 6, flavescent sophora root 6, Chinese pulsatilla root 6, psoralea fruit 6, magnolia obavata 3, banksia rose 3, cimicifuga rhizome 2.5, chebula fruit 6, musk 3 and coptis root 3.

The invention discloses a traditional Chinese preparation for treating chronic colitis. According to the characteristics of deficiency and excess Inclusion and cold-heat complex of chronic colitis and by focusing on regulating liver, kidneys, spleen and stomach of a patient, enhancing physique of people and improving an epidemic disease resistance force of a human body, mature monkshood, rhizome zingiberis, astragalus root, fried white atractylodes rhizome, immature bitter orange, radix linderae, cinnamon, corydalis tuber, dried orange peel, pinellia ternate and crude liquorice Chinese herbal medicines are selected and then prepared into decoction through reasonable matching. After the traditional Chinese preparation is clinically tried out in Qinan Traditional Chinese Medicine Hospital of Shandong Province, the cure rate reaches 76%, the total effective rate is 98%, and the curative effect is obviously superior to that of traditional Chinese medicines commonly used at current. The traditional Chinese preparation has the advantages of high clinical curative rate, low treatment cost and non toxic or side effect, and is worth popularizing and applying in clinic.

The present invention relates to a medicine composition for treating colitis and a preparing method thereof. The medicine composition is composed of codonopsis pilosula, stir-fried bighead atractylodes rhizome, stir-fried rhizome atractylodis, calculus bovis, coptis, costus root, medicated leaven, scorch-fried whitethorn, ledebouriella root, white peony root, poria cocos wolf, baked ginger, cortex fraxini, smoked plum and pericarpium citri reticulatae. The components are furnace-dried, crushed, sieved, sterilized and packaged to obtain the medicine. The medicine composition has the advantages of good curative effect to acute and chronic colitis, short treating period, high radical cure rate, and no toxic or side effect for human body.

The invention discloses a traditional Chinese medicine composition for treating chronic colitis, which is prepared from the following crude drugs by weight: 10g of atractylodes macrocephala, 10g of orange peel, 10g of szechwan chinaberry fruits, 10g of dangshen, 10g of radix aconite carmichaeli, 10g of magnolia officinalis, 10g of platycodon grandiflorum, 10g of radix aucklandiae, 12g of atractylodes lancea, 12g of angelica sinensis, 15g of tuckahoe, 15g of radix astragali, 20g of radix paeoniae alba, 25g of pulsatilla chinensis, 6g of liquorice, 6g of coptis roots and 3g of cinnamon. The traditional Chinese medicine composition can play roles in eliminating blood stasis and stopping pain, strengthening the spleen and stomach, warming Yang and invigorating Qi as well as reducing internal heat and checking diarrhea and has the advantages of good curative effect, short treatment course, medication safety, economy and reliability and the like.

The invention provides a medicine for treating senile chronic colitis. A preparation method of the medicine for treating senile chronic colitis comprises the following steps: adding fructus psoraleae, shiandra, nutmeg, fructus evodiae, cooked monkshood, dangshen, bighead atractylodes rhizome, costus root, red halloysite, pomegranate rind, dried ginger and licorice into water for decocting twice for 2-4 hours every time; concentrating the decoction into clear cream the relative density of which is 1.04-1.05 at 50 DEG C; drying under reduced pressure; crushing to obtain fine powder; and evenly mixing to obtain capsule products. The medicine provided by the invention has the functions of conditioning yin and yang, strengthening the spleen and replenishing qi, clearing heat and eliminating dampness and warming middle energizer to dispel cold and relieve pain, can be used for treating senile chronic colitis, can be easily and safely taken by patients, and can reduce the occurrence of complications; and by clinical observation, the effective rate of the medicine is 88.8%.

The invention discloses a traditional Chinese medicine composition for treating chronic colitis, which is prepared from the following raw medicines in proportions by weight: 12g of radix scutellariae, 30g of white peony root, 12g of coix seed, 10g of dangshen, 10g of tuckahoe, 10g of crinis carbonisatus, 10g of red halloysite, 10g of dried orange peel, 6g of coptis, 9g of bighead atractylodes rhizome, 9g of rhizoma cyperi, 9g of balloonflower, 3g of cassia, 6g of baked ginger, 6g of myrobalan and 5g of nutmeg. The traditional Chinese medicine composition has the functions of clearing away heat, promoting diuresis, strengthening the spleen, tonifying the kidney, warming the middle-jiao, promoting the circulation of qi, nourishing the blood and nourishing the liver, and has the advantages of exact treatment effect, high effect taking speed and small toxic side effect.